The move removes the requirement for prior regulatory approval to repatriate dividends and aligns intermediary rules with India's revised insurance and foreign investment framework.
Three South Korean insurers have held early stage discussions with Indian players, advisers, and the regulator, as they look to enter the US$130bn market.
